Published guidance, NICE advice and quality standards

Showing 691 to 700 of 1871

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer	TA639	1 July 2020	1 July 2020
Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma (terminated appraisal)	TA634	30 June 2020	30 June 2020
Ramucirumab with erlotinib for untreated EGFR-positive metastatic non-small-cell lung cancer (terminated appraisal)	TA635	30 June 2020	30 June 2020
Eculizumab for treating refractory myasthenia gravis (terminated appraisal)	TA636	30 June 2020	30 June 2020
Ranibizumab for treating diabetic retinopathy (terminated appraisal)	TA637	30 June 2020	30 June 2020
Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure	TA626	24 June 2020	24 June 2020
Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention	IPG673	24 June 2020	24 June 2020
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia	MTG49	24 June 2020	24 June 2020
Ustekinumab for treating moderately to severely active ulcerative colitis	TA633	17 June 2020	17 June 2020
Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test)	DG39	17 June 2020	17 June 2020